Drug interactions
Ertugliflozin-sitagliptin + Lonapegsomatropin
Severity: Moderate
Ertugliflozin-sitagliptin and Lonapegsomatropin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Growth hormone can reduce insulin sensitivity and raise blood glucose, which may counteract the effect of antidiabetic drugs. Patients with diabetes may need their regimen adjusted.
What this interaction means in plain words
Ertugliflozin-sitagliptin and Lonapegsomatropin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Ertugliflozin-sitagliptin belongs to Endocrine; Lonapegsomatropin belongs to Endocrine.
Why it happens
Growth hormone induced insulin resistance antagonizes the glucose-lowering effect of ertugliflozin and sitagliptin.
What to do
Monitor blood glucose when starting or changing the lonapegsomatropin dose, and adjust antihyperglycemic therapy as needed.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Ertugliflozin-sitagliptin and Lonapegsomatropin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Ertugliflozin-sitagliptin
Other interactions of Lonapegsomatropin
Frequently asked questions
Can I take Ertugliflozin-sitagliptin with Lonapegsomatropin?
MediHelp rates the interaction as moderate. Ertugliflozin-sitagliptin and Lonapegsomatropin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Growth hormone can reduce insulin sensitivity and raise blood glucose, which may counteract the effect of antidiabetic drugs. Patients with diabetes may need their regimen adjusted.
How serious is the interaction between Ertugliflozin-sitagliptin and Lonapegsomatropin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when starting or changing the lonapegsomatropin dose, and adjust antihyperglycemic therapy as needed.
What other medicines interact with Ertugliflozin-sitagliptin?
MediHelp also lists interactions of Ertugliflozin-sitagliptin with, for example, Albiglutide, Aripiprazole, Asenapine. The full list is on the Ertugliflozin-sitagliptin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
